The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy

Turkish Journal of Pediatrics

Volumn 44, Issue 1, 2002, Pages 1-4

  Tunç, Bahattin ^a   Öner, Ahmet F ^a   Hiçsönmez, Gönül ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acute leukemia; CD34+ progenitor cells; Children; High dose methylprednisolone

Indexed keywords

CD34 ANTIGEN; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNOL L;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; BONE MARROW CELL; CELL STIMULATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INFECTION; LEUKEMIA REMISSION; MALE; MONONUCLEAR CELL; NEUTROPHIL; SHORT COURSE THERAPY;

ADOLESCENT; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; METHYLPREDNISOLONE; REMISSION INDUCTION;

EID: 0036169460     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Clinicopathologic and cytogenic features of CD34 (My 10)/positive acute nonlymphocytic leukemia
2. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry
3. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood
4. Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants
5. The effect of high-dose methylprednisolone combined chemotherapy on CD34-positive cells in acute lymphoblastic leukemia
6. + progenitor cells in children with acute leukemia
7. Effect of high-dose methylprednisolone and G-CSF treatments on lymphocyte subtypes in neutropenic children with acute lymphoblastic leukemia: A pilot study
8. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies
9. Critical evaluation of massive steroid therapy of acute leukemia
10. High-dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia
11. High-dose methylprednisolone for children with acute lymphoblastic leukemia and unfavorable presenting features
12. A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia children with randomization
13. High-dose methylprednisolone sodiumsuccinate as a single agent in relapsed childhood acute lymphoblastic leukemia
14. Acceleration of leukocyte recovery by administration of short-course high-dose methylprednisolone in children with acute lymphoblastic leukemia
15. Differentiation of leukemic cells induced by short-course high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia
16. Morpohologic evidence of apoptosis in children with acute myeloblastic leukemia treated by high-dose methylprednisolone
17. The effect of high-dose methylprednisolone treatment on GM-CSF level in children with acute leukemia: A pilot study
18. Serum TNF-alfa, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone
19. Dexamethasone enhances "CSA" release and depresses "BPA" release
20. Glucocorticoid therapy in the preleukemic syndrome (hemopoietic dysplasia): Identification of responsive patients using in-vitro techniques
21. Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte-macrophage colony-forming cells
22. High dose intravenous glucocorticoid in the treatment of childhood acquired aplastic anaemia
23. High-dose intravenous corticosteroid treatment for patients with Diamond-Blackfan syndrome resistant or refractory to conventional treatment
24. High dose intravenous methylprednisolone for idiopathic myelofibrosis